PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34890967-6	2022	Inhibition of BTK by ibrutinib not only suppressed the migration and invasion-promoting ability, but also declined the increased expression of p-BTK, p-Akt, beta-catenin, and CSC markers upon REC8 overexpression.	ibrutinib	21-30	AKT serine/threonine kinase 1	Homo sapiens	152-155